CMH :: Clinical and Molecular Hepatology

Beneficial effects of the probiotics and synbiotics supplementation on anthropometric indices and body composition in adults: A systematic review and meta‐analysis

Saeede Saadati, Kaveh Naseri, Omid Asbaghi, Mohsen Yousefi, Elnaz Golalipour, Barbora de Courten

Roles of Traditional and Next-Generation Probiotics on Non-Alcoholic Fatty Liver Disease (NAFLD) and Non-Alcoholic Steatohepatitis (NASH): A Systematic Review and Network Meta-Analysis

Metabolic dysfunction-associated fatty liver disease: current therapeutic strategies

Khamis Al Hashmi, Rosaria Vincenza Giglio, Anca Pantea Stoian, Angelo Maria Patti, Khalid Al Waili, Khalid Al Rasadi, Marcello Ciaccio, Manfredi Rizzo

Gut microbiota and obesity: an overview of microbiota to microbial-based therapies

Elham Sheykhsaran, Amin Abbasi, Hamed Ebrahimzadeh Leylabadlo, Javid Sadeghi, Samaneh Mehri, Fariba Naeimi Mazraeh, Hadi Feizi, Hossein Bannazadeh Baghi

Postgraduate Medical Journal.2023; 99(1171): 384. CrossRef

The Crosstalk between Gut Microbiota and Bile Acids Promotes the Development of Non-Alcoholic Fatty Liver Disease

Effects of synbiotics supplementation on anthropometric and lipid profile parameters: Finding from an umbrella meta-analysis

Vali Musazadeh, Maryam Mohammadi Anilou, Mahdi Vajdi, Arash Karimi, Sana Sedgh Ahrabi, Parvin Dehghan

Using synbiotics supplementation to treat hepatic steatosis: A comprehensive meta-analysis of randomized controlled trials

Ammar Nojaid, Jason William, Krisanto Tanjaya, Nurpudji Astuti Taslim, Fahrul Nurkolis

Human Nutrition & Metabolism.2023; 32: 200194. CrossRef

Role of Probiotics and Gut microbiota in Liver Diseases

Safeena Beevi S S, Biju Pottakkat, Sankar Narayanan

Asian Journal of Nursing Education and Research.2023; : 157. CrossRef

Effects of Synbiotic-Containing Bacillus coagulans (GBI-30) on the Cardiovascular Status of Patients With Polycystic Ovary Syndrome: A Triple-blinded, Randomized, Placebo-controlled Study

Zahra Hariri, Zahra Yari, Sedighe Hoseini, Afsaneh Mehrnami, Khadijeh Abhari, Golbon Sohrab

Clinical Therapeutics.2023; 45(10): e193. CrossRef

Benefits of Combining Sonchus brachyotus DC. Extracts and Synbiotics in Alleviating Non-Alcoholic Fatty Liver Disease

Wenwu Huang, Boyuan Shen, Xiumei Li, Tongcun Zhang, Xiang Zhou

Protective Effects of Sitagliptin on Streptozotocin-Induced Hepatic Injury in Diabetic Rats: A Possible Mechanisms

Qamraa H. Alqahtani, Samiyah Alshehri, Ahlam M. Alhusaini, Wedad S. Sarawi, Sana S. Alqarni, Raessa Mohamed, Meha N. Kumar, Juman Al-Saab, Iman H. Hasan

Inulin as a Clinical Therapeutic Intervention in Metabolic Associated Fatty Liver Disease

Varenka Barbero-Becerra, Eva Juárez-Hernández, Norberto C Chávez-Tapia, Misael Uribe

Food Reviews International.2022; 38(sup1): 336. CrossRef

Therapeutic mechanisms and beneficial effects of non-antidiabetic drugs in chronic liver diseases

Han Ah Lee, Young Chang, Pil Soo Sung, Eileen L. Yoon, Hye Won Lee, Jeong-Ju Yoo, Young-Sun Lee, Jihyun An, Do Seon Song, Young Youn Cho, Seung Up Kim, Yoon Jun Kim

Clinical and Molecular Hepatology.2022; 28(3): 425. CrossRef

A randomized triple-blind controlled clinical trial evaluation of sitagliptin in the treatment of patients with non-alcoholic fatty liver diseases without diabetes

Azam Doustmohammadian, Ahmad Nezhadisalami, Fahimeh Safarnezhad Tameshke, Nima Motamed, Mansooreh Maadi, Mohammad Farahmand, Masoudreza Sohrabi, Cain C. T. Clark, Hossein Ajdarkosh, Amir Hossein Faraji, Mehdi Nikkhah, Elham Sobhrakhshankhah, Ramin Ebrahim

The promising role of probiotics/prebiotics/synbiotics in energy metabolism biomarkers in patients with NAFLD: A systematic review and meta-analysis

Shudi Li, Jiangkai Liu, Zhen Wang, Fei Duan, Zi Jia, Xinju Chen, Suling Li

Diagnostic and therapeutic strategies for non-alcoholic fatty liver disease

Yajie Fu, Yanzhi Zhou, Linhu Shen, Xuewen Li, Haorui Zhang, Yeqi Cui, Ke Zhang, Weiguo Li, Wei-dong Chen, Shizhen Zhao, Yunfu Li, Wenling Ye

Molecular mechanisms of metabolic associated fatty liver disease (MAFLD): functional analysis of lipid metabolism pathways

Olufunto O. Badmus, Sarah A. Hillhouse, Christopher D. Anderson, Terry D. Hinds, David E. Stec

A Systematic Review of Newer Antidiabetic Agents in the Treatment of Nonalcoholic Fatty Liver Disease

John A. Dougherty, Erenie Guirguis, Krisy-Ann Thornby

Annals of Pharmacotherapy.2021; 55(1): 65. CrossRef

The role of the gut microbiome and diet in the pathogenesis of non-alcoholic fatty liver disease

Clinical and Molecular Hepatology.2021; 27(1): 22. CrossRef

Pathophysiological Mechanisms in Non-Alcoholic Fatty Liver Disease: From Drivers to Targets

Alvaro Santos-Laso, María Gutiérrez-Larrañaga, Marta Alonso-Peña, Juan M. Medina, Paula Iruzubieta, María Teresa Arias-Loste, Marcos López-Hoyos, Javier Crespo

Nutritional supplementation for nonalcohol-related fatty liver disease: a network meta-analysis

Oluyemi Komolafe, Elena Buzzetti, Audrey Linden, Lawrence MJ Best, Angela M Madden, Danielle Roberts, Thomas JG Chase, Dominic Fritche, Suzanne C Freeman, Nicola J Cooper, Alex J Sutton, Elisabeth Jane Milne, Kathy Wright, Chavdar S Pavlov, Brian R Davids

Cochrane Database of Systematic Reviews.2021;[Epub] CrossRef

Efficacy of synbiotic supplementation in obesity treatment: A systematic review and meta-analysis of clinical trials

Amir Hadi, Kimia Alizadeh, Hossein Hajianfar, Hamed Mohammadi, Maryam Miraghajani

Critical Reviews in Food Science and Nutrition.2020; 60(4): 584. CrossRef

Effects of synbiotic consumption on lipid profile: a systematic review and meta-analysis of randomized controlled clinical trials

Amir Hadi, Ehsan Ghaedi, Saman Khalesi, Makan Pourmasoumi, Arman Arab

European Journal of Nutrition.2020; 59(7): 2857. CrossRef

The Role of Gut Microbiome-Targeted Therapy in Nonalcoholic Fatty Liver Disease

Current Hepatology Reports.2020; 19(4): 420. CrossRef

Gut microbiome–targeted therapies in nonalcoholic fatty liver disease: a systematic review, meta-analysis, and meta-regression

Suzanne R Sharpton, Bharat Maraj, Emily Harding-Theobald, Eric Vittinghoff, Norah A Terrault

The American Journal of Clinical Nutrition.2019; 110(1): 139. CrossRef

Incretin‐Based Therapies for the Management of Nonalcoholic Fatty Liver Disease in Patients With Type 2 Diabetes

A review of synbiotic efficacy in non-alcoholic fatty liver disease as a therapeutic approach

Diabetes & Metabolic Syndrome: Clinical Research & Reviews.2019; 13(5): 2917. CrossRef

Effects of probiotics on nonalcoholic fatty liver disease: a systematic review and meta-analysis

Yao Tang, Juan Huang, Wen yue Zhang, Si Qin, Yi xuan Yang, Hong Ren, Qin-bing Yang, Huaidong Hu

Therapeutic Advances in Gastroenterology.2019; 12: 175628481987804. CrossRef

Role of Probiotics in Non-alcoholic Fatty Liver Disease: Does Gut Microbiota Matter?

Combination of synbiotic and sitagliptin in nonalcoholic fatty liver disease: Is it better than sitagliptin alone?

Clinical and Molecular Hepatology.2018; 24(3): 299. CrossRef

Antidiabetic Drugs in NAFLD: The Accomplishment of Two Goals at Once?

Matteo Tacelli, Ciro Celsa, Bianca Magro, Aurora Giannetti, Grazia Pennisi, Federica Spatola, Salvatore Petta